Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$6.10 USD
+0.11 (1.84%)
Updated May 28, 2024 04:00 PM ET
After-Market: $6.10 0.00 (0.00%) 4:54 PM ET
4-Sell of 5 4
F Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Capricor Therapeutics, Inc. [CAPR]
Reports for Purchase
Showing records 81 - 82 ( 82 total )
Company: Capricor Therapeutics, Inc.
Industry: Medical - Products
CAP-1002 to Extend its (Cardio) Sphere of Influence into Muscular Dystrophy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Capricor Therapeutics, Inc.
Industry: Medical - Products
3Q14 Update -ALLSTARs Aligned for Enrolling Optimal Patient Population
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R